CytoMed Therapeutics (GDTC) Stock Price & Financial Analysis
CytoMed Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About CytoMed Therapeutics
What is the current stock price for GDTC?
As of the latest trading session, GDTC stock trades at $1.21. The 52-week range is $0.68–$3.68, with a day range of $1.11–$1.21.
What is the P/E ratio for GDTC?
The P/E ratio (Price-to-Earnings) for GDTC is shown in the Key Statistics section. This valuation metric helps compare CytoMed Therapeutics Limited to industry peers.
Does GDTC pay dividends?
CytoMed Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for GDTC?
Analyst ratings and recommendations for GDTC are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of GDTC?
CytoMed Therapeutics's market capitalization is $14.1M, classifying it as a micro-cap company. CytoMed Therapeutics operates in the Healthcare sector within the Biotechnology industry.